Neoadjuvant therapy followed by pancreaticoduodenectomy for resectable and borderline resectable pancreatic head cancer: A propensity score matched per protocol analysis. (2020) - Paci, M.; Yoh, T.; Tabchouri, N.; Benoist, O.; Hermand, H.; Cros, J.; Aussilhou, B.; Ftériche, Fs; Zappa, M.; Hentic, O.; Soubrane, O.; Hammel, P.; et al.